Get Published in Human Gene Therapy
All accepted abstracts from ICLE 2023 would be published in
Human Gene Therapy
(Impact Factor 4.793*)
*2021 Journal Citation Reports™ (Clarivate, 2022)
CiteScore™: 8.2
ABOUT HUMAN GENE THERAPY
Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.
To view all ICLE 2022 published abstracts, please click on the cover below:
ICLE 2022 Abstracts
Pages: A-1–A-42
Published Online: 30 March 2022
Editor-in-Chief: Terence R. Flotte, MD
Deputy Editor-in-Chief: Guangping Gao, PhD
European Editor: Hildegard Büning, PhD
Asian Editor: Yu-Quan Wei MD, PhD
Deputy Editors: Mark Kay, MD, PhD, Thierry VandenDriessche, PhD, and Cheng Seng, PhD